Lifemd, Inc. current report, Q3 FY2020

Vollständiges Dokument

Business Context and Reporting Period

This Form 8-K was filed by Conversion Labs, Inc. (not Lifemd, Inc.) on July 27, 2020. The filing reports the entry into a material definitive agreement involving the issuance of a secured convertible promissory note to an accredited investor.

Key Financial Metrics

  • Debt Instrument: Secured Convertible Promissory Note.
  • Principal Amount: Up to $1,500,000.
  • Initial Proceeds: $600,000 received as of the effective date.
  • Interest Rate: 1.25% per month.
  • Maturity Date: January 24, 2021.
  • Collateral: First priority security interest in all tangible and intangible property of the Company.
  • Revenue/Profit/Cash Flow: The filing text does not provide a clear value for revenue, profit, operating cash flow, or margins.

Material Changes

The Company has incurred a new direct financial obligation. The issuance of the Note represents a material change in the Company's capital structure, creating a liability that may convert into preferred stock upon a future "Qualified Financing" (defined as raising at least $2,500,000 in gross proceeds).

Guidance, Outlook, and Risks

  • Conversion Terms: Upon a Qualified Financing, the Investor may elect to convert the outstanding principal and accrued interest into shares of Preferred Stock at the same price paid by cash purchasers in that financing.
  • Events of Default: The Note contains customary events of default. If triggered, all obligations become immediately due and payable at the Investor's election.
  • Liquidity Risk: Additional advances beyond the initial $600,000 require the sole discretion of the Investor.
  • Management Commentary: The filing does not provide specific management commentary or forward-looking guidance beyond the terms of the Note.

Investor Verification Checklist

  • Verify the total outstanding principal and accrued interest on the Note as of the current date.
  • Confirm whether the Company has secured additional advances under the $1,500,000 cap.
  • Review the full text of the Secured Convertible Promissory Note (Exhibit 10.1) for specific default triggers and covenants.
  • Assess the Company's progress toward a "Qualified Financing" to determine the likelihood of debt conversion versus cash repayment.
  • Check for any subsequent filings regarding the status of the collateral pledged.